Paliperidone

CAS 144598-75-4

Overview

Paliperidone, sold under the brand name Invega among others, is an atypical antipsychotic. It is marketed by Janssen Pharmaceuticals. Invega is an extended release formulation of paliperidone that uses the OROS extended release system to allow for once-daily dosing

Anant Labs manufacture and furnish high quality Paliperidone impurities for global markets. Our Paliperidone EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Paliperidone

CAS 144598-75-4In Stock

Technical Data

CAS144598-75-4

Mol. FormulaC₂₃H₂₇FN₄O₃

Mol. Weight426.492 g/mol

IUPAC3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one

SMILESCC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F

InChIInChI=1S/C23H27FN4O3/c1-14-17(23(30)28-9-2-3-19(29)22(28)25-14)8-12-27-10-6-15(7-11-27)21-18-5-4-16(24)13-20(18)31-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3

InChI KeyPMXMIIMHBWHSKN-UHFFFAOYSA-N

Synonyms

Paliperidone144598-75-49-HydroxyrisperidoneInvegaRO76477R-76477PaliperidonaRO-764774H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-R 76477